LSA
ORGO icon

Leonteq Securities AG’s Organogenesis Holdings ORGO Stock Holding History

Leonteq Securities AG’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-221
Closed -$594 – 1294
2022
Q4 		$594 Sell
221
-173
-44% -$505 ﹤0.01% 1229
2022
Q3 		$1.28K Sell
394
-64
-14% -$289 ﹤0.01% 1204
2022
Q2 		$2.23K Buy
458
+2
+0.4% +$12 ﹤0.01% 1199
2022
Q1 		$3.48K Hold
456
– – ﹤0.01% 1182
2021
Q4 		$4.21K Buy
+456
New +$4.84K ﹤0.01% 1194

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Leonteq Securities AG's ORGO Position: Q1 2023 in Review

Leonteq Securities AG sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 221 shares — an estimated $594 sold.

Leonteq Securities AG first reported a position in ORGO in Q4 2021 and held it in 5 quarters. The position peaked at $4.21K in Q4 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Leonteq Securities AG reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 221 Organogenesis Holdings shares in Q1 2023, an estimated $594.
  • Leonteq Securities AG first reported a position in Organogenesis Holdings in Q4 2021 and held it in 5 quarters.
  • Leonteq Securities AG's Organogenesis Holdings position peaked at $4.21K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Leonteq Securities AG's 13F filing for Q1 2023, filed 11 Mar 2026.